Latest news
BioVie reports positive Phase 2 results for Parkinson's candidate bezisterim - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 13:03:00 GMTBioVie reports positive phase 2 Parkinson's results, eyes pivotal Phase 3 trial - Proactive financial newsProactive financial news · Thu, 06 Aug 2026 12:40:00 GMTIntellia Therapeutics reports Q2 2026 net loss of $106.6M, $628.4M cash; positive Phase 3 data for lonvo-z - TradingViewTradingView · Thu, 06 Aug 2026 11:53:01 GMTBioVie Reports Positive Phase 2 SUNRISE-PD Results for Bezisterim in Early Parkinson’s Disease - Quiver QuantitativeQuiver Quantitative · Thu, 06 Aug 2026 11:44:00 GMTIntellia Therapeutics Reports Positive Phase 3 HAELO Data for Lonvo-z, Advances Nex-z Trials and Reaffirms Cash Runway Into 2028 - Quiver QuantitativeQuiver Quantitative · Thu, 06 Aug 2026 11:15:00 GMTPfizer (PFE) Reports Positive Phase 3 LITFULO Data In Vitiligo - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 12:13:26 GMTRocket Pharmaceuticals Reports Positive Safety Update for RP-A501 Under Modified Phase 2 Protocol in Danon Disease - BioPharm InternationalBioPharm International · Mon, 03 Aug 2026 17:07:07 GMTMoleculin Biotech Reports Positive Pivotal Phase 2/3 Trial Results for Annamycin in AML - The Indian PractitionerThe Indian Practitioner · Mon, 03 Aug 2026 12:46:33 GMT